142 related articles for article (PubMed ID: 27706266)
1. Intermittent Parathyroid Hormone Improves Bone Formation Around Titanium Implants in Osteoporotic Rat Maxillae.
Park S; Heo HA; Kim KW; Min JS; Pyo SW
Int J Oral Maxillofac Implants; 2017; 32(1):204-209. PubMed ID: 27706266
[TBL] [Abstract][Full Text] [Related]
2. Effect of intermittent parathyroid hormone (1-34) treatment on the bone response after placement of titanium implants into the tibia of ovariectomized rats.
Shirota T; Tashiro M; Ohno K; Yamaguchi A
J Oral Maxillofac Surg; 2003 Apr; 61(4):471-80. PubMed ID: 12684966
[TBL] [Abstract][Full Text] [Related]
3. Enhancing Effect of Intermittent Parathyroid Hormone Administration on Bone Formation After Titanium Implant Placement in an Ovariectomized Rat Maxilla.
Heo HA; Park SH; Jeon YS; Pyo SW
Implant Dent; 2016 Apr; 25(2):227-31. PubMed ID: 26513040
[TBL] [Abstract][Full Text] [Related]
4. Intermittent administration of human parathyroid hormone (1-34) increases new bone formation on the interface of hydroxyapatitecoated titanium rods implanted into ovariectomized rat femora.
Ohkawa Y; Tokunaga K; Endo N
J Orthop Sci; 2008 Nov; 13(6):533-42. PubMed ID: 19089541
[TBL] [Abstract][Full Text] [Related]
5. Effects of Simvastatin on bone healing around titanium implants in osteoporotic rats.
Du Z; Chen J; Yan F; Xiao Y
Clin Oral Implants Res; 2009 Feb; 20(2):145-50. PubMed ID: 19077150
[TBL] [Abstract][Full Text] [Related]
6. Effect of Raloxifene on Bone Formation Around Implants in the Osteoporotic Rat Maxilla: Histomorphometric and Microcomputed Tomographic Analysis.
Park S; Heo HA; Min JS; Pyo SW
Int J Oral Maxillofac Implants; 2020; 35(2):249-456. PubMed ID: 32142560
[TBL] [Abstract][Full Text] [Related]
7. Intermittent administration of human parathyroid hormone (1-34) increases fixation of strontium-doped hydroxyapatite coating titanium implants via electrochemical deposition in ovariectomized rat femur.
Tao ZS; Zhou WS; Qiang Z; Tu KK; Huang ZL; Xu HM; Sun T; Lv YX; Cui W; Yang L
J Biomater Appl; 2016 Feb; 30(7):952-60. PubMed ID: 26482573
[TBL] [Abstract][Full Text] [Related]
8. The effects of combined human parathyroid hormone (1-34) and simvastatin treatment on osseous integration of hydroxyapatite-coated titanium implants in the femur of ovariectomized rats.
Tao ZS; Zhou WS; Tu KK; Huang ZL; Zhou Q; Sun T; Lv YX; Cui W; Yang L
Injury; 2015 Nov; 46(11):2164-9. PubMed ID: 26404665
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of peri-implant bone formation via parathyroid hormone administration in a rat model at risk for medication-related osteonecrosis of the jaw.
Park JY; Heo HA; Park S; Pyo SW
J Periodontal Implant Sci; 2020 Apr; 50(2):121-131. PubMed ID: 32395390
[TBL] [Abstract][Full Text] [Related]
10. Effect of alendronate and intermittent parathyroid hormone on implant fixation in ovariectomized rats.
Skripitz R; Johansson HR; Ulrich SD; Werner A; Aspenberg P
J Orthop Sci; 2009 Mar; 14(2):138-43. PubMed ID: 19337803
[TBL] [Abstract][Full Text] [Related]
11. PTH [1-34] enhances bone response around titanium implants in a rabbit model of osteoporosis.
Almagro MI; Roman-Blas JA; Bellido M; Castañeda S; Cortez R; Herrero-Beaumont G
Clin Oral Implants Res; 2013 Sep; 24(9):1027-34. PubMed ID: 22626278
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
[TBL] [Abstract][Full Text] [Related]
13. Effect of intermittent PTH administration in the periodontitis-associated bone loss in ovariectomized rats.
Marques MR; da Silva MA; Manzi FR; Cesar-Neto JB; Nociti FH; Barros SP
Arch Oral Biol; 2005 Apr; 50(4):421-9. PubMed ID: 15748695
[TBL] [Abstract][Full Text] [Related]
14. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
Shen V; Birchman R; Wu DD; Lindsay R
J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
[TBL] [Abstract][Full Text] [Related]
15. Effect of lycopene on titanium implant osseointegration in ovariectomized rats.
Li X; Xue W; Cao Y; Long Y; Xie M
J Orthop Surg Res; 2018 Sep; 13(1):237. PubMed ID: 30223885
[TBL] [Abstract][Full Text] [Related]
16. Effect of ovariectomy and alendronate on implant osseointegration in rat maxillary bone.
Viera-Negrón YE; Ruan WH; Winger JN; Hou X; Sharawy MM; Borke JL
J Oral Implantol; 2008; 34(2):76-82. PubMed ID: 18478902
[TBL] [Abstract][Full Text] [Related]
17. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
Rhee Y; Won YY; Baek MH; Lim SK
J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792
[TBL] [Abstract][Full Text] [Related]
18. [Effect of local application of insulin like growth factor-1 gelatin sponge complex on osseointegration around implant in osteoporosis rats].
Tang C; Li X; Wang F; Cui X; Zhu Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Jul; 50(7):418-22. PubMed ID: 26564746
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of Bone Augmentation in Osteoporotic Conditions by the Intermittent Parathyroid Hormone: An Animal Study in the Calvarium of Ovariectomized Rat.
Kubota T; Hasuike A; Naito M; Tsunori K; Min S; Sato S
Int J Oral Maxillofac Implants; 2018; 33(5):1003-1010. PubMed ID: 30231085
[TBL] [Abstract][Full Text] [Related]
20. Effects of continual intermittent administration of parathyroid hormone on implant stability in the presence of osteoporosis: an in vivo study using resonance frequency analysis in a rabbit model.
Oki Y; Doi K; Makihara Y; Kobatake R; Kubo T; Tsuga K
J Appl Oral Sci; 2017; 25(5):498-505. PubMed ID: 29069147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
